Article
Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.
Journal of lipid research - 1 Jun 2014
Morisseau Christophe, Wecksler Aaron T, Deng Catherine, Dong Hua, Yang Jun, Lee Kin Sing S, Kodani Sean D, Hammock Bruce D
Abstract excerpt
Epoxy FAs (EpFAs) are important lipid mediators that are mainly metabolized by soluble epoxide hydrolase (sEH). Thus, sEH inhibition is a promising therapeutic target to treat numerous ailments. Several sEH polymorphisms result in amino acid substitutions and alter enzyme activity. K55R and R287Q are associated with inflammatory, cardiovascular, and metabolic diseases. R287Q seems to affect sEH activity through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
